Back
Centessa Pharmaceuticals PLC 10K Form
Buy
77
CNTA
Centessa Pharmaceuticals PLC
Last Price:
16.54
Seasonality Move:
8.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CNTA News And Ratings
See the #1 stock for the next 7 days that we like better than CNTA
CNTA Financial Statistics
Sales & Book Value
| Annual Sales: | $6.85M |
|---|---|
| Cash Flow: | $-21.42M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.79 |
| Price / Book: | 4.46 |
Profitability
| EPS (TTM): | -1.52000 |
|---|---|
| Net Income (TTM): | $-161.27M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Centessa Pharmaceuticals PLC Earnings Forecast
Key Centessa Pharmaceuticals PLC Financial Ratios
- The Research & Development expenses have been 1,815.34% of Revenue.
- The Interest Expense is -6.56% of Operating Income.
- The Net Earning history of CNTA is -2,204.65% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 1 years.
Centessa Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CNTA |
| Website: | centessa.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CNTA Technical Analysis vs Fundamental Analysis
Buy
77
Centessa Pharmaceuticals PLC (CNTA)
is a Buy
Is Centessa Pharmaceuticals PLC a Buy or a Sell?
-
Centessa Pharmaceuticals PLC stock is rated a Buy
The current Centessa Pharmaceuticals PLC [CNTA] share price is $16.87. The Score for CNTA is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.